// App-Quantinova.ai

: Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Receiving ≥3 Lines of Therapy: A Real-World Evaluation in the United States

Researchers

Presenter

  • Allicia Girvan

Principal Investigators

  • Junhua Yu

  • Rajesh Kamalakar

  • Elizabeth S. Mearns

  • Michael Nixon

  • Robert F. Cornell

Medical Centers

  • N/A

Locations

  • United States

Companies

  • Genentech, Inc.

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisone

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved